Cite
HARVARD Citation
Roberti Maggiore, U. et al. (n.d.). 2022-RA-649-ESGO Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer. International journal of gynecological cancer. p. A250. [Online].